Corbus Pharmaceuticals Earning Date (CRBP)

USA |NASDAQ |USD

CRBP Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 14, 2022 Dec 2021 $-0.11 $-0.02 $-0.10
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 14, 2022 Dec 2021 $230.00K $97.32K $658.20K

Corbus Pharmaceuticals's next earnings date is Monday, Mar 14, 2022 for the fiscal quarter ending Dec 2021.

CRBP Earnings Date & History Chart

CRBP Earnings & Revenue Forecast

CRBP Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 1 $-0.11 $-0.11 $-0.11
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $-0.40 $-0.52 $-0.19

CRBP Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 0 / 0 $-0.11 $-0.12 $-0.12
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $-0.47 $-0.46 $-0.46

CRBP Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Mar 2022 1 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $9.04M $0.00 $25.00M

CRBP Earnings Date & Revenue History

CRBP Earnings History

|
Show More
Show More

CRBP Revenue History

|
Show More
Show More

Corbus Pharmaceuticals Next Earnings Date & Report

CRBP Next Earnings Date & Report Preview: Dec 2021 (FQ)

CRBP's next earnings date is Monday, Mar 14, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 4 analysts, the average EPS estimation for Corbus Pharmaceuticals's next quarterly earnings is $-0.11, with a low EPS estimation of $-0.12, and a high estimation of $-0.10.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.12, the last 2 month trend is $-0.10, and the 3 month trend is $-0.10.

Based on 3 analysts, the average revenue estimation is $230.00K, with a low revenue estimation of $0.00, and a high estimation of $500.00K.

Corbus Pharmaceuticals Previous Earnings Dates & Reports

CRBP Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Corbus Pharmaceuticals's previous earnings date was Nov 12, 2021 for its fiscal quarter ended Sep 30, 2021.

CRBP's earnings per share (EPS) was $-0.02, beating the consensus analysts forecast of $-0.11 by 81.82%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -86.67%, and higher than the same period a year before (Sep 2020) by -95.35%.

Revenues were $97.32K, worse than the forecast of $650.00K by -85.03%, down by -28.73% from the previous quarter , and down by -92.09% from the same period last year.

The company reported a net income of $-2.18M.

Free cash flow for the quarter was $856.95K , compared to $-17.53M last quarter and $-27.31M a year before.

CRBP ended the quarter with $25.90M in total debt, a decrease of -0.69% compared to the previous quarter, and an increase of 37.58% compared to the same quarter a year before.

CRBP Previous Earnings Date & Report Recap: Dec 2020 (FY)

Corbus Pharmaceuticals's previous annual earnings date was Mar 15, 2021 for its fiscal year ended Dec 31, 2020.

CRBP's earnings per share (EPS) was $-1.48, beating the consensus analysts forecast of $-1.61 by -8.07% , and lower than the previous year's EPS (Dec 2019) by 30.97%.

Revenues were $3.94M, worse than the forecast of $4.77M by -17.46%, and down by -89.11% from previous year's revenue.

The company reported a net income of $-111.27M.

Corbus Pharmaceuticals reported a free cash flow of $-100.17M for its fiscal year, compared to $-48.46M a year ago.

The company ended the fiscal year with $19.74M in total debt, an increase of 109.02% compared to the previous year.